Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
Insulin induces the expression of FGF2 but does not synergize with it during angiogenesis
Lakshmi Surekha Krishnapati1, Surendra Ghaskadbi1
1Developmental Biology Group, MACS-Agharkar Research Institute, Pune 411 004, India.
Abstract:
Cardiovascular and ischemic diseases are often associated with diabetes mellitus and develop due to occlusion of blood vessels leading to the blockage and insufficient blood supply to the target organs. Current therapeutic strategies for treating these pathologies include growth factor-, gene- and stem cell-based therapies. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) have been used in clinical trials to induce blood vessels. On the other hand, increased levels of both these growth factors have been observed with intense insulin therapy in diabetes mellitus patients further leading to increased risk of retinopathy. This suggests the presence of a possible crosstalk between insulin, FGF and VEGF pathways during angiogenesis. In the present work, we report the likely absence of synergistic effect between insulin and FGF-2. This was initially observed at morphological and histological levels using chick embryonic chorioallantoic membrane (CAM) assay and confirmed by analyzing the expression of angiogenesis regulatory genes by semi-quantitative reverse transcriptase PCR (RT-PCR). Absence of combinatorial effect between insulin, FGF-2 and VEGF during angiogenesis was also demonstrated using CAM assay.
Insights
This study investigated the interplay between insulin, fibroblast growth factor-2 (FGF-2), and vascular endothelial growth factor (VEGF) in blood vessel formation. Researchers found no evidence of a combined effect of insulin and FGF-2 on angiogenesis.
Area of Science:
- Biomedical research
- Molecular biology
- Cardiovascular science
Background:
- Cardiovascular and ischemic diseases are linked to diabetes mellitus, often caused by blocked blood vessels.
- Current treatments involve growth factors, gene therapy, and stem cells.
- Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) promote blood vessel growth but are elevated with insulin therapy, suggesting a potential link.
Purpose of the Study:
- To investigate the potential synergistic effect between insulin and FGF-2 in angiogenesis.
- To explore the combinatorial effects of insulin, FGF-2, and VEGF on blood vessel formation.
Main Methods:
- Chick embryonic chorioallantoic membrane (CAM) assay for morphological and histological analysis.
- Semi-quantitative reverse transcriptase PCR (RT-PCR) to analyze angiogenesis regulatory gene expression.
Main Results:
- Morphological and histological examination using the CAM assay indicated no synergistic effect between insulin and FGF-2.
- Gene expression analysis confirmed the absence of a combinatorial effect between insulin and FGF-2.
- The CAM assay also demonstrated no combined effect of insulin, FGF-2, and VEGF on angiogenesis.
Conclusions:
- Insulin and FGF-2 do not appear to have a synergistic role in promoting angiogenesis.
- The study suggests a lack of combinatorial effect between insulin, FGF-2, and VEGF in blood vessel formation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles
TGF - β Signaling Pathway

